Contact
Biography
I received Dipl. Eng. degree in Pharmacy from the School of Pharmacy and Biochemistry, University of Zagreb, Croatia. I worked for my master degree in Pharmaceutical Technology at Pharmacology and Therapeutics Department, McGill University, Montreal, Canada. I obtained PhD (Doctorate Medicine-Pharmacy) from University of Zagreb, Croatia for work completed under supervision of Prof SS Davis and Prof L Illum at the School of Pharmacy, University of Nottingham, UK.
Following PhD, I took up postdoctoral position at the School of Pharmacy at Nottingham, and was subsequently appointed Lecturer, Associate Professor in Advanced Drug Delivery, and promoted to Professor in Pharmaceutics at School of Pharmacy, University of Nottingham.
I held the Royal Society Industry Fellowship in 2007-2009.
I was Director of EPSRC Centre for Doctoral Training in Advanced Therapeutics and Nanomedicines, PI and Director of 2018 funded Centre for Doctoral Training in Transformative Pharmaceutical Technologies at University of Nottingham, University College London, SSPC Centre for Pharmaceuticals in Ireland, and a consortium of pharmaceutical and healthcare industry partners. I am also CI and co-Director of 2024 funded EPSRC Centre for Doctoral Training in Accelerated Medicines Design and Development, at University of Nottingham and UCL, and a consortium of pharmaceutical industrial partners.
http://www.transpharmtech-dtc.ac.uk/
Expertise Summary
My research lies at the interface of physicochemical characterisation and biological performance of drug delivery systems. Representative recent examples include studies on transport of nanoparticles into/across cells, and events at epithelium and at cell membrane (Molecular Pharmaceutics 2014, 2019, Scientific Reports 2018, Biochimica et Biophysica Acta-Bioenergetics 2019, Journal of Controlled Release 2022), ligand mediated delivery of colloidal polymeric systems (J Controlled Release 2012, 2013, 2020, Small 2013, Science Advances 2015, Advanced Therapeutics 2021) and 'cells in matrices' (J Biotechnology 2009, Bioconjugate Chemistry 2019, J of Pathology 2021).
https://orcid.org/0000-0002-2345-5062
Snow Stolnik Google Scholar
My research funding also includes a portfolio of industry-sponsored projects with NittoDenko Japan, UCB Celltech, Biocompatibles, AstraZeneca, MedImmune, Baxter, Critical Pharmaceuticals, Archimedes, Honda, and GSK.
Teaching Summary
Pharmaceutics lead on Gastrointestinal and liver diseases, and Central nervous system modules of MPharm course, and Advanced drug delivery, and Science in industry modules of MSci course.
Research Summary
My research lies at the interface of physicochemical characterisation and biological performance of drug delivery systems. Representative recent examples include studies on transport of nanoparticles… read more
Recent Publications
ALI ALAZZO, NURCAN GUMUS, PRATIK GURNANI, SNJEZANA STOLNIK, RUMAN RAHMAN, KEITH SPRIGGS and CAMERON ALEXANDER, 2022. Investigating histidinylated highly branched poly(lysine) for siRNA delivery J. Mater. Chem. B. 10(2), 236-246 SULAIMAN, SARAH, GERSHKOVICH, PAVEL, HOAD, CAROLINE L., CALLADINE, MATTHEW, SPILLER, ROBIN C., STOLNIK, SNOW and MARCIANI, LUCA, 2022. Application of In Vivo MRI Imaging to Track a Coated Capsule and Its Disintegration in the Gastrointestinal Tract in Human Volunteers PHARMACEUTICS. 14(2), CONTE, C., MONTEIRO, P.F., GURNANI, P., STOLNIK, S., UNGARO, F., QUAGLIA, F., CLARKE, P., GRABOWSKA, A.M., KAVALLARIS, M. and ALEXANDER, C., 2021. Multi-component bioresponsive nanoparticles for synchronous delivery of Docetaxel and TUBB3 siRNA to lung cancer cells Nanoscale. 13, 11414-11426 LINKE, FRANZISKA, ALDIGHIERI, MACHA, LOURDUSAMY, ANBARASU, GRABOWSKA, ANNA M., STOLNIK, SNOW, KERR, IAN D., MERRY, CATHERINE L. R. and COYLE, BETH, 2021. 3D hydrogels reveal medulloblastoma subgroup differences and identify extracellular matrix subtypes that predict patient outcome JOURNAL OF PATHOLOGY. 253(3), 326-338
Current Research
My research lies at the interface of physicochemical characterisation and biological performance of drug delivery systems. Representative recent examples include studies on transport of nanoparticles into/across cells, and events at epithelium and at cell membrane (Molecular Pharmaceutics 2014, 2019, Scientific Reports 2018, Biochimica et Biophysica Acta-Bioenergetics 2019, Journal of Controlled Release 2022), ligand mediated delivery of colloidal polymeric systems (J Controlled Release 2012, 2013, 2020, Small 2013, Science Advances 2015, Advanced Therapeutics 2021) and 'cells in matrices' (J Biotechnology 2009, Bioconjugate Chemistry 2019, J of Pathology 2021).
https://orcid.org/0000-0002-2345-5062
Snow Stolnik Google Scholar
My research funding also includes a portfolio of industry-sponsored projects with NittoDenko Japan, UCB Celltech, Biocompatibles, AstraZeneca, MedImmune, Baxter, Critical Pharmaceuticals, Archimedes, Honda, and GSK.